Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Receivables - Other (2023 - 2025)

Historic Receivables - Other for Connect Biopharma Holdings (CNTB) over the last 3 years, with Q3 2025 value amounting to $157000.0.

  • Connect Biopharma Holdings' Receivables - Other changed N/A to $157000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $157000.0, marking a year-over-year change of. This contributed to the annual value of $262000.0 for FY2024, which is 2535.61% down from last year.
  • Connect Biopharma Holdings' Receivables - Other amounted to $157000.0 in Q3 2025.
  • Over the past 5 years, Connect Biopharma Holdings' Receivables - Other peaked at $3.6 million during Q2 2024, and registered a low of $157000.0 during Q3 2025.
  • For the 3-year period, Connect Biopharma Holdings' Receivables - Other averaged around $781833.3, with its median value being $227500.0 (2024).
  • Per our database at Business Quant, Connect Biopharma Holdings' Receivables - Other crashed by 2535.61% in 2024 and then crashed by 9458.02% in 2025.
  • Connect Biopharma Holdings' Receivables - Other (Quarter) stood at $351000.0 in 2023, then decreased by 25.36% to $262000.0 in 2024, then plummeted by 40.08% to $157000.0 in 2025.
  • Its Receivables - Other stands at $157000.0 for Q3 2025, versus $193000.0 for Q2 2025 and $167000.0 for Q1 2025.